Improving Outcomes for Children Requiring Extracorporeal Membrane Oxygenation Therapy Following Hematopoietic Stem Cell Transplantation
- 6 January 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 49 (4), e381-e393
- https://doi.org/10.1097/ccm.0000000000004850
Abstract
Objectives: The objective of this study was to provide an updated review of survival for pediatric hematopoietic stem cell transplantation patients requiring extracorporeal membrane oxygenation therapy as well as characterize the demographics, clinical variables, and complications associated with mortality. Design: Retrospective database review of the Extracorporeal Life Support Organization Registry from 1990 to 2019. Setting: Extracorporeal membrane oxygenation centers reporting to Extracorporeal Life Support Organization. Patients: Patients treated with extracorporeal membrane oxygenation greater than 28 days to 18 years old with International Classification of Diseases Ninth Revision, International Classification of Diseases Tenth Revision, and current procedural terminology codes consistent with hematopoietic stem cell transplantation were included. Interventions: None. Measurements and Main Results: Demographics, year of extracorporeal membrane oxygenation run, clinical variables, comorbid diagnoses, and extracorporeal membrane oxygenation complications were assessed in relation to the primary study outcome of survival to hospital discharge. Ninety patients were included in the final analysis. The overall survival rate for the study period was 19%. However, the survival rate in the last decade (2010–2019) improved to 26% (p = 0.01; odds ratio 9.4 [1.2–74.8]). Factors associated with decreased survival included comorbid malignancy, elevated peak inspiratory pressure in conventionally ventilated patients, and pulmonary and metabolic complications on extracorporeal membrane oxygenation. Conclusions: Pediatric patients posthematopoietic stem cell transplantation supported with extracorporeal membrane oxygenation have improving survival rates over time. With 26% of patients (16/62) surviving to hospital discharge in the last decade (2010–2019), history of hematopoietic stem cell transplantation may no longer be considered an absolute contraindication to extracorporeal membrane oxygenation. As advancements are made in hematopoietic stem cell transplantation therapies and extracorporeal membrane oxygenation management, the indications for life-saving extracorporeal membrane oxygenation support among patients posthematopoietic stem cell transplantation may expand accordingly.Keywords
This publication has 55 references indexed in Scilit:
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationThe New England Journal of Medicine, 2010
- Successful use of extracorporeal life support in a hematopoietic stem cell transplant patient with diffuse alveolar hemorrhagePediatric Critical Care Medicine, 2010
- Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress SyndromeJAMA, 2009
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- Survival in a Recent Cohort of Mechanically Ventilated Pediatric Allogeneic Hematopoietic Stem Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2008
- Extracorporeal life support for severe respiratory failure in children with immune compromised conditions*Pediatric Critical Care Medicine, 2008
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging studyBlood, 2008
- Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experienceJournal of Pediatric Surgery, 2006
- Extracorporeal membrane oxygenation after stem cell transplant: Clinical decision-making in the absence of evidencePediatric Critical Care Medicine, 2005
- Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity surveyBone Marrow Transplantation, 2002